BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mantovani A, Dugo C. Ceramides and risk of major adverse cardiovascular events: A meta-analysis of longitudinal studies. J Clin Lipidol 2020;14:176-85. [PMID: 32067904 DOI: 10.1016/j.jacl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Gao X, Lin L, Hu A, Zhao H, Kang L, Wang X, Yuan C, Yang P, Shen H. Shotgun lipidomics combined targeted MRM reveals sphingolipid signatures of coronary artery disease. Talanta 2022;245:123475. [DOI: 10.1016/j.talanta.2022.123475] [Reference Citation Analysis]
2 Boulet MM, Calzada C, Pettazzoni M, Lelekov-Boissard T, Buisson C, Di Filippo M, Durand A, Lambert-Porcheron S, Nazare JA, Moulin P, Michalski MC, Cheillan D. A meal rich in palm oil or butter modifies the sphingolipid profile of postprandial triglyceride-rich lipoproteins from type 2 diabetic women. Biochimie 2022:S0300-9084(22)00179-1. [PMID: 35817131 DOI: 10.1016/j.biochi.2022.07.003] [Reference Citation Analysis]
3 Mantovani A, Csermely A, Sani E, Beatrice G, Petracca G, Lunardi G, Bonapace S, Lippi G, Targher G. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes. Biomolecules 2022;12:943. [DOI: 10.3390/biom12070943] [Reference Citation Analysis]
4 Kluger NJ, Legget ME. Emerging Biomarkers in Acute Coronary Syndromes - A Pathophysiologic Perspective. Heart Lung Circ 2022;31:779-86. [PMID: 35283017 DOI: 10.1016/j.hlc.2022.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Papazoglou AS, Stalikas N, Moysidis DV, Otountzidis N, Kartas A, Karagiannidis E, Giannakoulas G, Sianos G. CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: a systematic review and meta-analysis. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.02.001] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tkachev AI, Stekolshchikova EA, Morozova AY, Anikanov NA, Zorkina YA, Alekseyeva PN, Khobta EB, Andreyuk DS, Zozulya SA, Barkhatova AN, Klyushnik TP, Reznik AM, Kostyuk GP, Khaitovich PE. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia. Consortium Psychiatricum 2021;2:35-43. [DOI: 10.17816/cp101] [Reference Citation Analysis]
7 Rivas Serna IM, Sitina M, Stokin GB, Medina-Inojosa JR, Lopez-Jimenez F, Gonzalez-Rivas JP, Vinciguerra M. Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health. Metabolites 2021;11:747. [PMID: 34822405 DOI: 10.3390/metabo11110747] [Reference Citation Analysis]
8 Camacho-Muñoz D, Kiezel-Tsugunova M, Kiss O, Uddin M, Sundén M, Ryaboshapkina M, Lind L, Oscarsson J, Nicolaou A. Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease. FASEB J 2021;35:e21976. [PMID: 34618982 DOI: 10.1096/fj.202100380RRR] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Carrard J, Gallart-Ayala H, Weber N, Colledge F, Streese L, Hanssen H, Schmied C, Ivanisevic J, Schmidt-Trucksäss A. How Ceramides Orchestrate Cardiometabolic Health-An Ode to Physically Active Living. Metabolites 2021;11:675. [PMID: 34677390 DOI: 10.3390/metabo11100675] [Reference Citation Analysis]
10 Luong TTD, Tuffaha R, Schuchardt M, Moser B, Schelski N, Boehme B, Gollmann-Tepeköylü C, Schramm C, Holfeld J, Pieske B, Gulbins E, Tölle M, van der Giet M, Lang F, Eckardt KU, Voelkl J, Alesutan I. Acid sphingomyelinase promotes SGK1-dependent vascular calcification. Clin Sci (Lond) 2021;135:515-34. [PMID: 33479769 DOI: 10.1042/CS20201122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kwon YJ, Lee GM, Liu KH, Jung DH. Effect of Korean Red Ginseng on Plasma Ceramide Levels in Postmenopausal Women with Hypercholesterolemia: A Pilot Randomized Controlled Trial. Metabolites 2021;11:417. [PMID: 34202864 DOI: 10.3390/metabo11070417] [Reference Citation Analysis]
12 Le Barz M, Vors C, Combe E, Joumard-Cubizolles L, Lecomte M, Joffre F, Trauchessec M, Pesenti S, Loizon E, Breyton AE, Meugnier E, Bertrand K, Drai J, Robert C, Durand A, Cuerq C, Gaborit P, Leconte N, Bernalier-Donadille A, Cotte E, Laville M, Lambert-Porcheron S, Ouchchane L, Vidal H, Malpuech-Brugère C, Cheillan D, Michalski MC. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women. JCI Insight 2021;6:146161. [PMID: 33857018 DOI: 10.1172/jci.insight.146161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Carrard J, Gallart-Ayala H, Infanger D, Teav T, Wagner J, Knaier R, Colledge F, Streese L, Königstein K, Hinrichs T, Hanssen H, Ivanisevic J, Schmidt-Trucksäss A. Metabolic View on Human Healthspan: A Lipidome-Wide Association Study. Metabolites 2021;11:287. [PMID: 33946321 DOI: 10.3390/metabo11050287] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Choi RH, Tatum SM, Symons JD, Summers SA, Holland WL. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat Rev Cardiol 2021. [PMID: 33772258 DOI: 10.1038/s41569-021-00536-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
15 Carvalho LSF, Chaves-Filho AB, Yoshinaga MY. Orchestrating a ceramide-phosphatidylcholine cardiovascular risk score: it ain't over 'til the fat layer sings. Eur J Prev Cardiol 2021:zwab012. [PMID: 34038516 DOI: 10.1093/eurjpc/zwab012] [Reference Citation Analysis]
16 Tabassum R, Ripatti S. Integrating lipidomics and genomics: emerging tools to understand cardiovascular diseases. Cell Mol Life Sci 2021;78:2565-84. [PMID: 33449144 DOI: 10.1007/s00018-020-03715-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cirillo F, Piccoli M, Ghiroldi A, Monasky MM, Rota P, La Rocca P, Tarantino A, D'Imperio S, Signorelli P, Pappone C, Anastasia L. The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction. J Cell Physiol 2021;236:4857-73. [PMID: 33432663 DOI: 10.1002/jcp.30235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Diaz SO, Sánchez-Quesada JL, de Freitas V, Leite-Moreira A, Barros AS, Reis A. Exploratory analysis of large-scale lipidome in large cohorts: are we any closer of finding lipid-based markers suitable for CVD risk stratification and management? Anal Chim Acta 2021;1142:189-200. [PMID: 33280696 DOI: 10.1016/j.aca.2020.10.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhao Y, Xu H, Tian Z, Wang X, Xu L, Li K, Gao X, Fan D, Ma X, Ling W, Yang Y. Dose-dependent reductions in plasma ceramides after anthocyanin supplementation are associated with improvements in plasma lipids and cholesterol efflux capacity in dyslipidemia: A randomized controlled trial. Clin Nutr 2021;40:1871-8. [PMID: 33131908 DOI: 10.1016/j.clnu.2020.10.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Meeusen JW, Donato LJ, Kopecky SL, Vasile VC, Jaffe AS, Laaksonen R. Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors. Clin Chim Acta 2020;511:138-42. [PMID: 33058843 DOI: 10.1016/j.cca.2020.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kovilakath A, Jamil M, Cowart LA. Sphingolipids in the Heart: From Cradle to Grave. Front Endocrinol (Lausanne) 2020;11:652. [PMID: 33042014 DOI: 10.3389/fendo.2020.00652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Tu C, Xie L, Wang Z, Zhang L, Wu H, Ni W, Li C, Li L, Zeng Y. Association between ceramides and coronary artery stenosis in patients with coronary artery disease. Lipids Health Dis 2020;19:151. [PMID: 32586390 DOI: 10.1186/s12944-020-01329-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mantovani A, Lunardi G, Bonapace S, Dugo C, Altomari A, Molon G, Conti A, Bovo C, Laaksonen R, Byrne CD, Bonnet F, Targher G. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease. Diabetes Metab 2021;47:101152. [PMID: 32283179 DOI: 10.1016/j.diabet.2020.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]